Cytori Therapeutics (CYTX) Reports In-Line Q1 Loss of 7c/Share

Cytori Therapeutics (NASDAQ: CYTX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $2.44 million.

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.

You May Also Be Interested In

• Nike (NKE) Tops Q1 EPS by 4c
• Roth/MKM Starts Suja Life Inc. (SUJA) at Buy
• Brady sells French first-aid unit Securimed for ~$59 million